Echoes of the type of thinking surrounding the delay in Novartis ratifying the ARDS deal they had signed:
that was because...
1. they wanted to renegotiate a higher price
2. they wanted to license congestive heart failure treatment
3. they wanted to buy Mesoblast
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-13475
-
- There are more pages in this discussion • 4,384 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
93.3¢ |
Change
0.048(5.37%) |
Mkt cap ! $1.061B |
Open | High | Low | Value | Volume |
88.5¢ | 95.0¢ | 88.0¢ | $3.133M | 3.411M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 46461 | 93.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.5¢ | 49789 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 43961 | 0.930 |
19 | 121886 | 0.925 |
17 | 208334 | 0.920 |
17 | 815486 | 0.915 |
7 | 139313 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 26160 | 9 |
0.940 | 73957 | 12 |
0.945 | 122594 | 12 |
0.950 | 98626 | 13 |
0.955 | 23000 | 3 |
Last trade - 12.24pm 06/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
MSB (ASX) Chart |